Retatrutide Study on Type 2 Diabetes with Obesity or Overweight Completed | Retatrutide News

A study on Retatrutide for type 2 diabetes in obese or overweight patients has been completed. The trial lasted about 89 weeks and involved up to 24 vis...
Clinical Trials · October 10, 2026